HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal earnings

This article was originally published in The Rose Sheet

Executive Summary

First half operating profit grew 7.8% to $1.37 bil. (€1=$1.22) on a strategy of cost control and like-for-like sales growth, firm reports Sept. 1. Adjusted operating profit was $1.4 bil., up 1%, and net income rose 21.8% to $1.2 bil. Cosmetics adjusted operating profit was $1.36 bil., while Dermatology contributed a $11.8 mil., L'Oréal adds. Company reported consolidated sales of $917 bil., up 6.4% like-for-like, or 3.6% on a reported basis, in July (1"The Rose Sheet" July 12, 2004, In Brief). Separately, the firm recently opened the first Lancôme concept store carrying the brand's makeup, skin care and fragrances in Hong Kong. Company plans to open 10 new stores this year in Asia and the U.S. and will open the renovated Lancôme Institute in Paris...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel